Results 11 to 20 of about 11,928,997 (202)

Ghrelin Levels in Male Patients with Hyperlipoproteinemia I, II versus Type 2 Diabetes Mellitus.

open access: yesمجلة كلية الطب, 2014
Background; Hyperlipoproteinemia (HLP)  are divided in primary and secondary subtypes. Primary HLP is usually due to genetic causes. Secondary HLP is resulting from another underlying disorder such as diabetes mellitus that leads to alterations in plasma
Salma A. Abbas   +2 more
doaj   +2 more sources

Clinical utility gene card for: hyperlipoproteinemia, TYPE II. [PDF]

open access: yesEur J Hum Genet, 2014
Kassner U   +5 more
europepmc   +5 more sources

2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea [PDF]

open access: yesJournal of Lipid and Atherosclerosis, 2022
Familial hypercholesterolemia (FH) is the most common monogenic disorder. Due to the marked elevation of cardiovascular risk, the early detection, diagnosis, and proper management of this disorder are critical.
Chan Joo Lee   +7 more
doaj   +2 more sources

Milky Plasma, Murky Diagnosis: Urgent Plasma Exchange for Severe Hypertriglyceridemia-Induced Hyperviscosity Without Pancreatitis, but With Myocardial Infarction. [PDF]

open access: yesJ Clin Apher
ABSTRACT Severe hypertriglyceridemia can increase the risk of acute pancreatitis, but also clinically significant hyperviscosity syndrome characterized by the typical signs of neurologic and visual manifestations. Hyperviscosity syndrome is a well‐established medical emergency.
Bodnar C   +3 more
europepmc   +2 more sources

Familial hypercholesterolemia within cardiology practice – single-center experience during 2-year period

open access: yesResearch in Cardiovascular Medicine, 2022
Background: Familial hypercholesterolemia (FH) is an inherited disorder characterized by significantly elevated levels of low-density lipoprotein (LDL) cholesterol and is usually diagnosed after the occurrence of major adverse cardiovascular event.
Edin Begic   +17 more
doaj   +1 more source

Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia [PDF]

open access: yesEndocrinology and Metabolism, 2021
Patients with familial hypercholesterolemia (FH) are at high or very high risk for cardiovascular disease. Those with heterozygous FH (HeFH) often do not reach low-density lipoprotein cholesterol (LDL-C) targets with statin and ezetimibe therapy, and ...
Brian Tomlinson   +3 more
doaj   +1 more source

Individualized Treatment for Patients With Familial Hypercholesterolemia

open access: yesJournal of Lipid and Atherosclerosis, 2022
Familial hypercholesterolemia (FH) is one of the most common and, therefore, important inherited disorders in preventive cardiology. This disease is mainly caused by a single pathogenic mutation in the low-density lipoprotein receptor or its associated ...
Hayato Tada   +2 more
doaj   +1 more source

Pseudohomozygous type II hyperlipoproteinemia [PDF]

open access: yesJapanese journal of human genetics, 1982
A 12-month-old boy with clinical findings suggestive of homozygous familial hypercholesterolemia, who had no secondary causes of hypercholesterolemia, and whose parents had no lipid abnormalities, was reported. No abnormalities were noted in the low density lipoprotein (LDL) receptor activities of the fibroblasts from patient, parents and sibling.
K, Hamada   +8 more
openaire   +2 more sources

Molecular diagnosis methods in familial hypercholesterolemia

open access: yesAnatolian Journal of Cardiology, 2020
Familial hypercholesterolemia (FH) is considered the genetic cause of coronary heart disease and ischemic stroke. FH is mainly an autosomal codominant pattern-based disorder and is primarily determined by point mutations within the low-density ...
Valeriu Moldovan   +2 more
doaj   +1 more source

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia [PDF]

open access: yesDiabetes & Metabolism Journal, 2015
Glucose and lipid metabolism are linked to each other in many ways. The most important clinical manifestation of this interaction is diabetic dyslipidemia, characterized by elevated triglycerides, low high density lipoprotein cholesterol (HDL-C), and ...
Klaus G. Parhofer
doaj   +1 more source

Home - About - Disclaimer - Privacy